Skip to content

A STUDY OF INDRAVARUNI MALHAR (OINTMENT) IN THE TREATMENT OF BREAST ENGORGEMENT (STANASHOTHA) IN SUTIKA (POST- NATAL)

A SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF INDRAVARUNI MALHAR (OINTMENT) IN BREAST ENGORGEMENT (STANASHOTHA) IN SUTIKA (POST-NATAL)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037954
Enrollment
40
Registered
2021-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O922- Other and unspecified disorders ofbreast associated with pregnancy and the puerperium

Interventions

None listed

Sponsors

DR SONALI SAMPAT GHORPADE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) LACTATING MOTHER FROM 1 TO 45 DAY AFTER DELIVERY 2) FULL TERM NORMAL DELIVERY AND LOWER SEGMENT CAESAREAN SECTION WHO IS SUFFERING FROM SYMPTOMS SUCH AS HEAVINESS(GURUTA), SWELLING(SHOTHA), TENDERNESS(SPARSHASAHATVA) IN BREAST

Exclusion criteria

Exclusion criteria: 1) ANTENATAL PATIENTS 2) PATIENTS HAVING HISTORY OF , OR CURRENTLY SUFFERING FROM ANY MALIGNANCY 3) FIBROCYSTIC CHANGES 4) BREAST LUMPS 5) BREAST ABCESS

Design outcomes

Primary

MeasureTime frame
TO OBSERVE THE EFFICACY OF INDRAVARUNI MALHAR(OINTMENT) IN SWELLING (SHOTHA) ,PAIN(SHOOL),TENDERNESS(SPARSHASAHATVA), REDNESS(AARAKTAVARNA) IN BREAST ENGORGEMENT(STANASHOTHA)Timepoint: INDRAVARUNI MALHAR(OINTMENT) WILL BE GIVEN FOR LOCAL APPLICATION FOR 6 DAYS FOLLOW UPS WILL BE ON 2ND 4TH 6TH DAY

Secondary

MeasureTime frame
TO DO THE ANALYTICAL STUDY OF INDRAVARUNI MALHAR TO OBSERVE THE ADVERSE EFFECT OF INDRAVARUNI MALHAR IN BREAST ENGORGEMENTTimepoint: INDRAVARUNI MALHAR(OINTMENT) WILL BE GIVEN FOR LOCAL APPLICATION FOR 6 DAYS FOLLOW UPS WILL BE ON 2ND 4TH 6TH DAY

Countries

India

Contacts

Public ContactDR SMRITIKA MOHANRAO TAWARE

DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE PIMPRI PUNE 18

bhonsalesmritika@gmail.com9850967067

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026